Author: Gonzalo Alvaro

Laboratorios Farmacéuticos ROVI today presented its financial results for the first quarter of 2023.

Don’t miss the video with the highlights

click on the following image to see it

Book Day is coming to ROVITECA and to celebrate it we have prepared a special selection of the most popular titles among our users.

Do you want to know which titles they are? Here is the list

Open your first challenge for “Book Day”.

Enter the challenges section and add the first one with one of the books we recommend. Take advantage of the platform to improve your reading habits.

If you have suggestions for new titles, let us know!

Go to the menu and click on “Content suggestions”. Help us to keep this platform growing in content. Recommend new books that you would like to read or some that you have loved and are missing. We will review them to expand the catalogue.

In order to draw up the ROVI Equality Plan 2022/2026, ROVI carried out an equality questionnaire with the workforce, receiving 503 responses.

Do you want to know the answers?

Check out the following video we have prepared.

The Universidad Pontificia Comillas, in collaboration with Laboratorios Farmacéuticos ROVI, has created a new Chair of Innovation and Digital Mental Health to respond to the psychological effects that digitalization may have on society. Additionally, this Chair will also analyze how technology can help improve mental health, life quality, and the care provided to all people.

“We are at a historical moment because the global effects of the pandemic have caused great psychological damage to our society and because, for the first time, one of the primary objectives of the Government and public and private institutions is to allocate human and financial resources to improve mental health in Spain”, said Dr. Lucía Halty, the Chair’s director.

The new Chair at Comillas has the support of Laboratorios Farmacéuticos ROVI. For its Chairman and CEO, Juan López-Belmonte, “this project represents an opportunity to obtain deeper knowledge of the impact of the new technologies on mental health in our society. In addition, it allows us to enhance the dialogue in the academic, healthcare and workplace contexts regarding current models for mental health detection, preventionprevention, and intervention.

The COVID-19 crisis has shown that the traditional model of access to healthcare resources, particularly psychological resources, needs to evolve. Companies and institutions should redesign the system and introduce new technologies to ensure progress and continuing improvement. Technology and mental health should go hand in hand to improve the care that people receive.

The Chair of Innovation and Mental Health at Comillas spans a good number of faculties and university disciplines. Although the greatest weight of the Chair will be borne by the Faculty of Human and Social Sciences (Comillas CIHS), the Faculties of Engineering (Comillas ICAI) and Law (Comillas ICADE), as well as the San Juan de Dios School of Nursiing and Physiotherapy, will also be involved. Thus, mental health will be approached from a multi-disciplinary holistic perspective that seeks to ensure people’s wellbeing in a digitalised environment

Don’t miss the whole story behind the ROVI’s Forest and the reforestation of the Valley of Dreams.

Don’t miss the video we have prepared for you. Click on the following image to watch it.

Laboratorios Farmacéuticos ROVI announces its incorporation as a member of the General Assembly of the Spanish Association of Biosimilar Medicines, BioSim. This is another milestone for both entities.

Laboratorios Farmacéuticos ROVI is a group of the pharmaceutical sector of Spanish origin, specialized, fully integrated and dedicated to the research, development, manufacture under license and commercialization of small molecules and biological specialties. Since 2017, the group has boosted its international presence thanks to the commercialization of its enoxaparin biosimilar. For ROVI, joining Biosim means joining “the work of an essential actor in the dissemination of knowledge and the promotion of biosimilar medicines in Spain, quality therapeutic alternatives that contribute to the sustainability of the health system”.

For BioSim, for its part, the incorporation of ROVI represents an advance in the representativeness of the Association as a reference for laboratories that research, develop, produce and/or market biosimilar medicines, with common principles and objectives. Thus, through different initiatives, both organizations will continue to promote the use of biosimilar medicines and transfer their value to the administration, health professionals, patients and the general public.

In the words of Encarna Cruz, CEO of BioSim “ROVI, as one of the pioneering companies that develops and produces biosimilars in Spain and markets internationally, is an example of a company that bets and encourages national employment and biosimilars. From BioSim we thank you for joining the Association and we believe that it can enrich the debates and decisions that are taken from now on. ”

This incorporation, in addition, adds the president of BioSim, Joaquín Rodrigo, increases the representativeness of the Association that currently has companies that occupy more than 95% of the Spanish biosimilar market. This allows us to strengthen our role as an interlocutor before administrations, managers, health professionals and patients. With its incorporation, the company wants to contribute its experience in the bioisimilars market. “Our enoxaparin biosimilar has become one of the main value generators of the group. We started its commercialization in 2017 and, since then, it has been a great boost to ROVI’s internationalization strategy and we hope that it will continue to be a lever of growth for our company in the coming years, ”explains Pedro Carretero, director of Hospitals and Institutional Relations of ROVI Laboratories and representative of the group in Biosim.

To improve the vending service, a change of supplier has been made from Selecta to Alliance Vending.

Due to this change, the old cards will be withdrawn and the new ones will be issued. For this reason, it is recommended that the balance of the old cards be used up before the withdrawal deadlines:

The new vending machines will be located in the canteen areas of each headquarters. We hope you enjoy them.

Visit ROVI’s facilities, solve the challenges and find the albarellos.

ROVI presented its ISM® technology platform at the meeting of the Innovation Committee of the Institute for the Development and Integration of Healthcare (IDIS Foundation). The debate was attended by Pedro Carretero Trillo, Director of Hospitals and Institutional Relations; Ibon Gutierro Adúriz, Director of R&D, and Javier Martínez González, Medical Director.

Throughout the colloquium, a presentation was made showing the advances throughout history in relation to long-acting injectables and the importance of achieving a reduction in symptomatology as quickly as oral treatment. In this sense, the results of ISM® Technology, designed to combine the sequential effect of three different mechanisms to control the release of active ingredients, were highlighted, as it provides therapeutic levels as fast as oral medication and maintains them in a sustained and predictable way.

Since 2011, the “Equal Pay Day” has been celebrated in Spain every 22 February, taking as a reference a European Parliament Resolution on the application of the principle of equal pay for men and women (2008/2012(INI)).
men and women (2008/2012(INI)).

The aim of this day is to highlight the fact that men and women should receive equal pay for work of equal value. Currently, despite the regulatory development and the great progress made in terms of equal treatment and opportunities between women and men in recent years, both at European and national level, equal pay has not been consolidated.

At ROVI we are committed to the fulfilment of SDG 5 on Gender Equality and the objectives set out in our Equality Plan, with a firm commitment to guarantee equal pay for the entire workforce. For this reason, we carry out annual salary studies that seek to detect differences in salary between men and women for work of equal value in order to be able to correct them if they occur.

In this respect, in accordance with our values, the ROVI Group’s management works actively to ensure that there are no inequalities of any kind within the company.